Autopsy report · NCT01475305

Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)

“The study was terminated as it was determined to not be feasible to complete enrollment and the study within the required timeline and budget.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 2 months before it stopped.
• 7 participants enrolled.
• Results were posted on the registry 4 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

MedImmune LLC

Sponsor type

Industry

Conditions

RSV Infection

Interventions

Placebo; MEDI-557

Participants

7

Sites

1

Countries

United Kingdom

Trials that died the same way

• Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.
  “The study was terminated due to additional regulatory requirements that could not be completed within the established academic timeline. As a result, continuation of the study was not feasible.” (88% match in meaning)
• Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
  “The study was terminated because of significant enrollment challenges” (85% match in meaning)
• The Effect of Blended Sensor Efficiency on Relieving the Heart's Inability to Increase Its Rate During Exercise
  “The study was terminated due to poor enrollment.” (85% match in meaning)
• A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
  “The study was terminated due to low enrollment.” (85% match in meaning)
• An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
  “Study terminated due to lack of enrollment of the target population. There were no safety, efficacy, or regulatory interaction involved in the decision to stop enrollment.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.